Observe Medical ASA – Primary insider notice

30 June 2020 - 17:30

Reference is made to the ongoing rights issue of 4,090,909 new shares (the "Offer Shares") at a subscription price of NOK 11.00 per share in Observe Medical ASA (the "Company") as announced in the Company's stock exchange announcement on 19 June 2020 (the "Rights Issue").

Primary insider, Kathrine Gamborg Andreassen, a member of the Company's board of directors, has today, on 30 June 2020, through her wholly-owned company Soleglad Invest AS, sold 144,428 subscription rights to subscribe for Offer Shares in the Rights Issue at a price of NOK 1.60 per subscription right.

Following the sale of the subscription rights, Kathrine Gamborg Andreassen, with related parties, holds no subscription rights to subscribe for Offer Shares in the Rights Issue and a total of 541,668 shares and 125,000 options in the Company.

This information is subject to disclosure requirements pursuant to section 4-2 of the Norwegian Securities Trading Act.

Provided by: Cision
Oslo Axess (Norway)
Observe Medical ASA
Observe Medical develop and market innovative hospital products that contribute to increased patient safety and a more efficient care system. Headquarter is in Oslo and operations in Sweden. First product: Sippi®, the only digital urine meter with wireless data transfer to patient data management system and which also prevents bacterial migration which can lead to urinary infections (Sippcoat®). S...
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date